SShabanan Profile Banner
Sedi Shabanan Profile
Sedi Shabanan

@SShabanan

Followers
615
Following
2K
Statuses
108

MD-MPH @TehUofMed, PGY1 @StanfordGenSurg, former radiology postdoc @UCSDHealthSci

Palo Alto, CA
Joined April 2022
Don't wanna be here? Send us removal request.
@SShabanan
Sedi Shabanan
2 days
RT @JeffChoi01: ⚪️USMLE Step 1, most preclinical 📖+ clinical rotations=pass/fail ⚪️Many dean’s letters refrain from categorically ranking g…
0
7
0
@SShabanan
Sedi Shabanan
5 days
Read more: Check out the full study in @Radiology_RSNA for details on methodology, subgroup analyses, and clinical implications. DM or comment your thoughts! Link: #RadInTraining
0
0
0
@SShabanan
Sedi Shabanan
2 months
7/ 🚨 Take-home point: Early risk stratification, intensive follow-up, and adherence to guidelines can save lives. Let's bridge the gap between evidence and practice. Full article for the details:
0
0
2
@SShabanan
Sedi Shabanan
2 months
RT @RSNA: We are so glad the dedicated members of our 5 Trainee Editorial Boards could join us for breakfast this morning. Thank you for al…
0
25
0
@SShabanan
Sedi Shabanan
2 months
RT @frahmanimd: Incredible turn out yesterday at our Radiology in Training Editorial Q&A session 🤯 Thanks everyone for joining and make sur…
0
7
0
@SShabanan
Sedi Shabanan
2 months
RT @frahmanimd: Such fun breakfast with the RIT squad 😃☀️ @RITEditor #RadInTraining #RSNA2024 @DrLindaMoy @VChernyakMD Wanna know more ❓…
0
10
0
@SShabanan
Sedi Shabanan
2 months
Check out the v2024 #LIRADS US Surveillance update and this excellent summary by our RadiologyInTraining star! @LIRADS5 @ayakamaya @RadiologyACR @RITEditor
@FarhadPishgar
Farhad Pishgar
2 months
Exciting update! #LIRADS US Surveillance v2024 refines how we monitor patients at risk for hepatocellular carcinoma (HCC). Here's a thread breaking down the updates and why they matter for clinical practice. 🧵 #RadInTraining #Tweetorial @AyaKamaya @RadiologyACR @DrLindaMoy
Tweet media one
1
1
39
@SShabanan
Sedi Shabanan
2 months
1
0
1